New York, New York 10010


Purpose:

The investigators plan to compare the impact of two approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life among a diverse population of patients at the Manhattan campus of the VA New York Harbor Healthcare System, which serves a critical safety-net role for urban veterans. During hospitalization, all smokers will receive usual care. Patients will be randomized to one of two arms: financial incentives plus usual care vs. usual care alone, which includes referral to the state Quitline. All patients enrolled in the study will be offered nicotine replacement therapy. The investigators will conduct follow-up assessments at 2 weeks, 2 months, 6 months and 12 months after discharge. The primary study outcome is smoking abstinence at 6-month follow-up, verified by salivary/urinary cotinine.


Criteria:

Inclusion Criteria: 1. age ≥ 18 years, 2. smoked tobacco during the prior 30 days, 3. have an active U.S. phone number and address, 4. can provide consent in English and 5. are in at least the contemplative stage of change for quitting smoking, as assessed by a single measure, readiness to quit Exclusion Criteria: 1. use only smokeless tobacco, 2. are pregnant or breastfeeding, 3. are discharged to an institution (e.g., nursing home, long-term care facility), 4. are unable to provide informed consent, or do not have cognitive ability to enroll or participate in the study


NCT ID:

NCT02506829


Primary Contact:

Principal Investigator
Joseph Ladapo, MD, PhD
New York University School of Medicine

Joseph Ladapo, MD, PhD
Phone: 646-501-2561
Email: joseph.ladapo@nyumc.org


Backup Contact:

Email: Jeremy.Abolade@va.gov
Jeremy Abolade
Phone: 212-686-7500 ext. 3015


Location Contact:

New York, New York 10010
United States

Sadozai Malik, BS
Phone: 212-686-7500
Email: sadozai.malik@va.gov

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 22, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.